Moore-Palhares, Daniel
Chen, Hanbo
Keith, Julia
Wang, Michael
Myrehaug, Sten
Tseng, Chia-Lin
Detsky, Jay
Perry, James
Lim-Fat, Mary Jane
Heyn, Chris
Maralani, Pejman
Lipsman, Nir
Das, Sunit
Sahgal, Arjun
Soliman, Hany
Article History
Received: 2 April 2023
Accepted: 11 May 2023
First Online: 31 May 2023
Change Date: 28 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11060-023-04364-w
Declarations
:
: SM reports research support and honoraria from AAA/Novartis and Ipsen. CLT reports consulting fees from Sanofi, honoraria from Elekta, and is Member of Elekta MR-Linac Research Consortium. SD reports research grants from Alkermes Medical and consultant fees from Medexus. AS reports grants from Elekta, Varian, Seagen, and BrainLAB; consulting fees from Varian, Elekta, BrainLAB, Merck, Abbvie, and Roche; honoraria from AstraZeneca, Elekta, Varian, BrainLAB, Accuracy, and Seagen. He is also an associate editor for the Journal of Neuro-Oncology, Vice President of the International Stereotactic Radiosurgery Society (ISRS), co-chair of the AO Spine Knowledge Forum Tumor, member to the Elekta MR Linac Research Consortium, Clinical Steering Committee member, and chairs the Elekta Oligometastases Group and the Elekta Gamma Knife Icon Group. All other authors have no disclosures.